Back to News
Market Impact: 0.4
Anthropic says Claude AI helped discover novel enzyme system
Source: reuters.com
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
Anthropic said its Claude AI model helped discover a novel enzyme system with properties resembling CRISPR gene-editing mechanisms, representing the first output from the startup's biology research initiative. The result highlights potential expansion of generative AI into biotech discovery, though no commercialization timeline or financial impact was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.70
More News
- China's AI chip blitz arms Xi with a message for Trump: 'You can't choke us off'
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- Meta announces new lightweight virtual reality glasses to one-up Apple’s Vision Pro
- US aviation sanctions disrupt Iran flights, push travellers overland
- Markets are rapidly coming around to the reality that the Fed has a lot more work to do
- Chinese authorities reportedly in possession of F-35 components in Hong Kong
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Automating Financial Model Updates: A Source-Controlled Workflow
- Weekly Update: Live Event Center, In-App Documents, and Faster Transcripts